Group One Trading’s Raptor Pharmaceutical RPTP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-160,615
| Closed | -$1.44M | – | 5319 |
|
|
2016
Q3 | $1.44M | Sell |
160,615
-218,869
| -58% | -$1.56M | 0.02% | 1029 |
|
|
2016
Q2 | $2.04M | Sell |
379,484
-41,380
| -10% | -$212K | 0.02% | 820 |
|
|
2016
Q1 | $1.94M | Sell |
420,864
-513,419
| -55% | -$2.06M | 0.03% | 788 |
|
|
2015
Q4 | $4.86M | Sell |
934,283
-331,147
| -26% | -$1.92M | 0.06% | 381 |
|
|
2015
Q3 | $7.66M | Sell |
1,265,430
-54,336
| -4% | -$666K | 0.11% | 213 |
|
|
2015
Q2 | $20.8M | Buy |
1,319,766
+265,937
| +25% | +$3.23M | 0.29% | 53 |
|
|
2015
Q1 | $11.5M | Buy |
1,053,829
+331,266
| +46% | +$3.38M | 0.18% | 86 |
|
|
2014
Q4 | $7.6M | Buy |
722,563
+32,971
| +5% | +$322K | 0.11% | 173 |
|
|
2014
Q3 | $6.61M | Sell |
689,592
-370,295
| -35% | -$3.78M | 0.1% | 212 |
|
|
2014
Q2 | $12.2M | Buy |
1,059,887
+79,585
| +8% | +$725K | 0.19% | 85 |
|
|
2014
Q1 | $9.8M | Buy |
980,302
+640,155
| +188% | +$9.24M | 0.16% | 106 |
|
|
2013
Q4 | $4.43M | Buy |
+340,147
| New | +$4.68M | 0.07% | 297 |
|
Group One Trading's RPTP Position: Q4 2016 in Review
Group One Trading sold out of Raptor Pharmaceutical (RPTP) in Q4 2016, closing a stake of 160,615 shares — an estimated $1.44M sold.
Group One Trading first reported a position in RPTP in Q4 2013 and held it in 12 quarters. The position peaked at $20.8M in Q2 2015. 0 funds tracked by Wall St. Rank hold RPTP as of Q4 2016.
- Group One Trading reported no remaining Raptor Pharmaceutical position as of Q4 2016 after selling out during the quarter.
- Group One Trading sold 160,615 Raptor Pharmaceutical shares in Q4 2016, an estimated $1.44M.
- Group One Trading first reported a position in Raptor Pharmaceutical in Q4 2013 and held it in 12 quarters.
- Group One Trading's Raptor Pharmaceutical position peaked at $20.8M in Q2 2015.
- 0 funds tracked by Wall St. Rank held Raptor Pharmaceutical as of Q4 2016.
Based on Group One Trading's 13F filing for Q4 2016, filed 15 Feb 2017.